Bicara Therapeutics Inc. ... (BCAX)
NASDAQ: BCAX
· Real-Time Price · USD
14.40
0.70 (5.11%)
At close: May 15, 2025, 3:59 PM
14.47
0.49%
After-hours: May 15, 2025, 04:05 PM EDT
5.11% (1D)
| Bid | 10.32 |
| Market Cap | 785.32M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -68M |
| EPS (ttm) | -4.05 |
| PE Ratio (ttm) | -3.56 |
| Forward PE | -5.47 |
| Analyst | Buy |
| Ask | 17.99 |
| Volume | 251,089 |
| Avg. Volume (20D) | 610,905.4 |
| Open | 13.72 |
| Previous Close | 13.70 |
| Day's Range | 13.21 - 14.49 |
| 52-Week Range | 8.91 - 28.09 |
| Beta | -1.49 |
About BCAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BCAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BCAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+7.98%
Bicara Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
